Stolper CO Gilead Sciences, Inc. Transaction History

Stolper CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 11, 2021	SELL	$56.65 - $64.55 $934,498 - $1.06 Million	-16,496 Closed	0 $0
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $3,974 - $4,997	-64 Reduced 0.39%	16,496 $1.04 Million
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $38,340 - $44,520	-530 Reduced 3.1%	16,560 $1.27 Million
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $1.07 Million - $1.37 Million	17,090 New	17,090 $1.28 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Stolper CO, based on Form 13F filings with the SEC.

Stay updated on Stolper CO with notifications on news.